Igfbp7 Products By Gene Name

HAF019). A specific band was detected for IGFBP-rp1/IGFBP-7 at approximately 30 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1." class="big_lightbox"> HAF019). A specific band was detected for IGFBP-rp1/IGFBP-7 at approximately 30 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1." alt="Western blot shows lysates of HepG2 human hepatocellular carcinoma cell line. PVDF membrane was probed with 1 µg/mL of Goat Anti-Human IGFBP-rp1/IGFBP-7 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1334) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF019). A specific band was detected for IGFBP-rp1/IGFBP-7 at approximately 30 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1." class="big_thumb" />

CTS008) and counterstained with hematoxylin (blue). Specific staining was localized to islets. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections." class="big_lightbox"> CTS008) and counterstained with hematoxylin (blue). Specific staining was localized to islets. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections." class="big_thumb" />

MAB13342) coated on a Clear Polystyrene Microplate (Catalog # DY990). Mouse Anti-Human IGFBP-rp1/IGFBP-7 Monoclonal Antibody (Catalog # MAB1334) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998) followed by Substrate Solution (Catalog # DY999) and stopping the enzymatic reaction with Stop Solution (Catalog # DY994)." class="big_lightbox"> MAB13342) coated on a Clear Polystyrene Microplate (Catalog # DY990). Mouse Anti-Human IGFBP-rp1/IGFBP-7 Monoclonal Antibody (Catalog # MAB1334) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998) followed by Substrate Solution (Catalog # DY999) and stopping the enzymatic reaction with Stop Solution (Catalog # DY994)." alt="Recombinant Human IGFBP-rp1/IGFBP-7 protein was serially diluted 2-fold and captured by Mouse Anti-Human IGFBP-rp1/IGFBP-7 Monoclonal Antibody (Catalog # MAB13342) coated on a Clear Polystyrene Microplate (Catalog # DY990). Mouse Anti-Human IGFBP-rp1/IGFBP-7 Monoclonal Antibody (Catalog # MAB1334) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998) followed by Substrate Solution (Catalog # DY999) and stopping the enzymatic reaction with Stop Solution (Catalog # DY994)." class="big_thumb" />

366-6C) that produces 50% of the optimal binding response is approximately 4-20 ng/mL." class="big_lightbox"> 366-6C) that produces 50% of the optimal binding response is approximately 4-20 ng/mL." alt="Recombinant Human IGFBP-rp1/IGFBP-7 (K95R) (Catalog # 1334-B7) binds Recombinant CCL21/6Ckine in a functional ELISA. When Recombinant Human IGFBP-rp1/IGFBP-7 (K95R) is immobilized at 500 ng/mL (100 µL/well), the concentration of Recombinant Human CCL21/6Ckine (Catalog # 366-6C) that produces 50% of the optimal binding response is approximately 4-20 ng/mL." class="big_thumb" />